| Product Name: | Oxymetazoline Hydrochloride |
| Synonyms: | 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol;hydrochloride |
| CAS No: | 2315-02-08 |
| Chemical Formula: | C16H24N2O.ClH |
| Grade: | IP/BP/USP |
| Appearance | White to off-white Solid powder |
| Molar Mass: | 296.83 g/mol |
| Solubility: | Soluble in water and alcohol |
Description
Chemignition is a leading manufacturer and exporter of Oxymetazoline Hydrochloride Active Pharmaceutical Ingredients (API) worldwide. The company adheres to strict Quality Management Systems (QMS) to ensure compliance with Good Manufacturing Practices (cGMPs). This commitment to quality and regulatory standards guarantees that Chemignition produces Oxymetazoline Hydrochloride of the highest quality and efficacy.
Oxymetazoline Hydrochloride serves primarily as a nasal decongestant and vasoconstrictor, effectively relieving nasal congestion associated with colds, allergies, and sinusitis by constricting blood vessels in the nasal passages.
During the manufacturing of Active Pharmaceutical Ingredients (API) and specialty chemicals, Chemignition employs various processes, including dissolution, charcoalization, filtration, leaching, extraction, crystallization, and purification.
Manufacturers commonly use Oxymetazoline Hydrochloride API to produce pharmaceutical products such as nasal sprays and eye drops.
The U.S. Food and Drug Administration (FDA) first approved Oxymetazoline Hydrochloride in 1963. It is available in various formulations, including nasal sprays, and is widely recognized for its effectiveness in relieving nasal congestion.
Storage Condition: Pack Oxymetazoline Hydrochloride in a double polybag, keep it in a tightly closed HDPE container, and store it at a temperature between 15°C and 30°C